Yeon Hee Park
Clinical trials sponsored by Yeon Hee Park, explained in plain language.
-
New combo therapy aims to slow advanced breast cancer in patients who relapsed
Disease control Not yet recruitingThis study tests whether a combination of two drugs (fulvestrant and ribociclib) works better than standard treatments for people with a certain type of advanced breast cancer (HR+, HER2-). The cancer has returned after the patient finished a prior course of CDK4/6 inhibitors. Ab…
Phase 2 • Sponsor: Yeon Hee Park • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Can Real-World data match trial results for pembrolizumab in Triple-Negative breast cancer?
Knowledge-focused Not yet recruitingResearchers in Korea are reviewing medical records from about 2,000 patients with triple-negative breast cancer who received pembrolizumab plus chemotherapy before surgery. The study measures how many patients had no detectable cancer left in their breast and lymph nodes at surge…
Sponsor: Yeon Hee Park • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC